This study compares two treatments for severe mitral regurgitation (MR), a condition where the heart's mitral valve leaks. It tests a device called MitraClip™ against traditional surgery. MitraClip™ is a small device that clips the leaky parts of the mitral valve together. The study is for people with serious MR who are at moderate risk for surgery. To take part, you must be 18 or older with severe MR and meet other conditions set by heart specialists. You can't join if you've had recent heart surgery or certain other heart problems. Key points:

• Study involves treatment with MitraClip™ or surgery; it's for moderate surgical risk patients.
• Participants must be at least 18 years old and have severe MR.
• Exclusions include recent surgery, some heart conditions, and certain other health issues.

Joining means you'll need to give written consent. The study's outcome could help determine if MitraClip™ is a safer, effective option compared to surgery. Participation could involve regular check-ups and follow-up visits to ensure safety and effectiveness.